TOXOPLASMA GONDII BY PCR (EDTA WHOLE BLOOD)

The TOXOPLASMA GONDII BY PCR (EDTA WHOLE BLOOD) test detects the genetic material (DNA) of Toxoplasma gondii in EDTA‑anticoagulated whole blood using molecular PCR techniques. By directly identifying parasite DNA, this assay is designed to indicate active or recent parasitemia rather than past exposure, making it especially useful when rapid and specific evidence of infection is required.

This test is commonly used for evaluating suspected acute infections in pregnant women, diagnosing congenital infection in neonates, and assessing immunocompromised patients (for example, those with HIV or transplant recipients) who present with fever, neurological or ocular symptoms. Samples are collected as EDTA whole blood by trained phlebotomists at home across Dubai, processed in accredited laboratories, and results are reported to the ordering clinician to support timely treatment decisions.

• Toxoplasma gondii DNA (Qualitative PCR)
• Cycle threshold (Ct) value (if detected)
• PCR internal control (assay validity)
• Sample type: EDTA whole blood

• Pregnant women with suspected recent exposure or seroconversion
• Newborns/infants suspected of congenital toxoplasmosis
• Immunocompromised patients with fever, encephalitis, or ocular symptoms
• Patients with unexplained lymphadenopathy or neurological signs suggestive of toxoplasmosis
• When confirmation of active infection is needed to guide or monitor therapy

• Direct detection of active infection through DNA amplification
• High analytical sensitivity and specificity compared with indirect serology for active disease
• At‑home EDTA whole blood collection by trained phlebotomists across Dubai
• Fast laboratory turnaround (typically 24–48 hours) and clinician‑ready reports
• Clinically useful for pregnancy management and immunocompromised patient care

• EDTA whole blood sample collected by a trained phlebotomist (typically 3–5 mL)
• No fasting required prior to collection
• Inform collector of recent blood transfusions or current antiparasitic therapy
• Provide valid ID and referring clinician details for report delivery to UAE healthcare providers